AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Xilda-M 500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Dios Lifesciences Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Xilda-M 500 Tablet SR

Xilda-M 500 SR tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like nephropathy and vision impairment, potentially lessening the risk of cardiovascular events. Xilda-M 500 SR may be administered independently or in conjunction with other antidiabetic therapies. Optimal therapeutic outcomes necessitate adherence to a balanced diet and consistent physical activity. Dosage is personalized based on individual health status, glycemic readings, and concurrent medications. Consuming this medication with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes efficacy; discontinuation should only occur under medical supervision. The medication actively regulates blood sugar, preventing future complications. Maintaining the prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Frequently reported adverse reactions include diarrhea, nausea, emesis, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; prompt recognition and management are essential. This medication isn't universally suitable. Prior to commencing treatment, individuals with pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption should consult their physician. Pregnant or lactating women require medical guidance before initiating therapy. Potential drug interactions necessitate disclosure of all medications to your doctor to ensure treatment safety. Alcohol should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout the course of treatment.

Primary Ingredients of Xilda-M 500 Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Xilda-M 500 Tablet SR

Managing type 2 diabetes

Major Benefits of Xilda-M 500 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Xilda-M 500 Tablet SR with a meal.

Common Side effects of Xilda-M 500 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Xilda-M 500 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Xilda-M 500mg Extended-Release tablets should be administered with a meal.

How Xilda-M 500 Tablet SR works:

The extended-release Xilda-M 500mg tablet contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Xilda-M 500 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Xilda-M 500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. Your physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Xilda-M 500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Extended-release Xilda-M 500 mg tablets require careful administration for individuals with impaired renal function. Dosage modification of Xilda-M 500 mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Xilda-M 500 SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Xilda-M 500 Tablet SR :

Should you forget to take a Xilda-M 500 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Xilda-M 500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Xilda-M 500 Tablet SR

Xilda-M 500 Tablet SR rarely causes hypoglycemia by itself, but low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Xilda-M 500 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Xilda-M 500 Tablet SR is contraindicated in patients allergic to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Xilda-M 500 SR tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Xilda-M 500 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, and heavy alcohol users. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Xilda-M 500 Tablet SR and seek immediate medical attention.
Prolonged use of Xilda-M 500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Xilda-M 500 Tablet SR is safe when used as directed by your doctor. However, even with proper dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (especially if taking insulin or sulphonylurea). Report any persistent side effects to your physician.
Xilda-M 500 Tablet SR
105
MRP 122
13% off